Joanna Robles, MD, first began having unusual symptoms in the summer of 2020. She had bouts of nausea and vomiting that she couldn’t explain. Eventually doctors diagnosed her with neuromyelitis optica ...

AstraZeneca and its global biologics research and development arm, MedImmune, today announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Designation for the investigational ...

Autoimmune diseases are the molecular equivalent of "friendly fire": the body attacks itself instead of harmful invaders. Now, researchers from Japan have found that interrupting the complex interplay ...

Researchers have identified a new therapy for patients with neuromyelitis optica that appears to stop inflammation of the eye nerves and spinal cord. NMO is a debilitating central nervous system ...

A monoclonal antibody (mAb) against a glycoprotein called repulsive guidance molecule-a (RGMa) may provide an efficient therapeutic strategy for treating neuromyelitis optica (NMO), scientists at ...

In the autoimmune disorder neuromyelitis optica (NMO), the immune system attacks the optic nerves and spinal cord. This can cause symptoms such as loss of vision and changes in sensation. Early and ...

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). This rare but severe ...

WASHINGTON -- Patients with IgG4-related disease appeared to benefit from inebilizumab (Uplizna), currently approved for neuromyelitis optica (NMO), in a pivotal clinical trial. Just 10% of patients ...

Please provide your email address to receive an email when new articles are posted on . Ultomiris is a C5 complement inhibitor for neuromyelitis optica spectrum disorder. Trial patients did not ...

A woman who contracted a rare disease that left her paralyzed from the waist down and visually impaired had initially put her symptoms down to a hangover. Annabelle Moult, a 39-year-old woman from ...